![Mark Vignola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Vignola
Plus aucun poste en cours
Profil
Mark J.
Vignola is currently Chief Financial Officer at Korsana Biosciences, Inc. since 2026.
Former roles include Chief Financial Officer & Treasurer at Terns Pharmaceuticals, Inc. from 2021 to 2025, Chief Financial Officer at Applied Therapeutics, Inc. from 2019 to 2020, Head-Corporate Development at Intercept Pharmaceuticals, Inc. from 2018 to 2019, Equity Research Associate at Needham & Co. LLC from 2011 to 2015, Research Assistant at Duke University Medical Center in 2011, and Analyst at Lehman Brothers, Inc. in 2000.
Education includes a doctorate from Duke University School of Medicine, a graduate degree from Duke University in 2002, and an undergraduate degree from Boston College in 1999.
Postes actifs de Mark Vignola
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Mark Vignola
| Sociétés | Poste | Fin |
|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Directeur Financier/CFO | 01/02/2025 |
| APPLIED THERAPEUTICS, INC. | Directeur Financier/CFO | 01/05/2020 |
| INTERCEPT PHARMACEUTICALS, INC. | Investor Relations Contact | 01/05/2019 |
Needham & Co. LLC
 Needham & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/05/2015 |
Duke University Medical Center
 Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2011 |
Formation de Mark Vignola
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Lehman Brothers, Inc.
 Lehman Brothers, Inc. Investment Banks/BrokersFinance Provides investment banking services | Finance |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Needham & Co. LLC
Needham & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Boston College
 Boston College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University Medical Center
Duke University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Applied Therapeutics, Inc.
 Applied Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative drugs and technologies for debilitating diseases | Health Technology |
Terns Pharmaceuticals, Inc.
 Terns Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops small-molecule product candidates to address serious diseases including oncology and obesity | Health Technology |
